N-acetyl-cysteine

DRUG5 trials

Sponsors

National Jewish Health, Universidade Estadual de Maringá, Ain Shams University, University of California, Irvine, The First Affiliated Hospital of Soochow University

Conditions

Bipolar DisorderClomiphene Citrate Resistant Polycystic Ovary SyndromeCognitive ImpairmentOvarian CancerPulmonary SarcoidosisThrombotic Disorder

Phase 1

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

RecruitingNCT04520139

University of California, IrvineCognitive Impairment, Ovarian Cancer

Start: 2026-05-21End: 2027-12-01Target: 102Updated: 2026-07-17

Phase 2

NAC in CC Resistant PCOS After LOD

CompletedNCT02775734

Ain Shams UniversityClomiphene Citrate Resistant Polycystic Ovary Syndrome

Start: 2016-05-31End: 2017-03-31Updated: 2017-05-02

Phase 3

The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation

The First Affiliated Hospital of Soochow UniversityThrombotic Disorder

Start: 2023-08-01End: 2025-12-01Target: 260Updated: 2023-06-18

Phase 4

Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder

Universidade Estadual de MaringáBipolar Disorder

Start: 2014-09-30End: 2015-09-30Target: 130Updated: 2015-04-17

Unknown Phase

The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

CompletedNCT01587001

National Jewish HealthPulmonary Sarcoidosis

Start: 2011-11-30End: 2014-10-31Updated: 2020-11-04

Related Papers

Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein.

2018-03-1330 citations